News Release

2022.05.18 Other

Salonpas_® Named the World’s No.1 OTC Topical Analgesic Patch Brand for the Sixth Consecutive Year

2022.04.21 Research and Development

Notification of application for manufacturing and marketing approval of HP-5070 (primary palmar hyperhidrosis treatment drug) in Japan

2022.04.07 lR Information

FY02/2022 Q4 Results Earnings Release Presentation

2022.03.23 Subsidiaries and Affiliated Companies

Noven Pharmaceuticals, Inc. press release : FDA Approves Once-Daily XELSTRYM™ (dextroamphetamine) Transdermal System, CII, for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients 6 Years and Older

2022.01.14 lR Information

Notice regarding Results and Completion of Acquisition of Treasury Shares

2022.01.13 lR Information

FY02/2022 Q3 Results Earnings Release Presentation